Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 49% ± 21% | |
eye | 8 studies | 38% ± 19% | |
lung | 7 studies | 29% ± 10% | |
peripheral blood | 4 studies | 17% ± 0% | |
heart | 4 studies | 36% ± 8% | |
liver | 3 studies | 35% ± 18% | |
intestine | 3 studies | 19% ± 3% | |
adipose | 3 studies | 41% ± 14% | |
kidney | 3 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2811.10 | 1445 / 1445 | 100% | 21.57 | 183 / 183 |
breast | 100% | 2955.76 | 459 / 459 | 100% | 19.52 | 1117 / 1118 |
brain | 100% | 3895.54 | 2639 / 2642 | 100% | 19.87 | 705 / 705 |
lung | 100% | 3415.95 | 578 / 578 | 100% | 15.67 | 1153 / 1155 |
intestine | 100% | 3047.86 | 966 / 966 | 100% | 13.57 | 526 / 527 |
ovary | 100% | 2373.44 | 180 / 180 | 100% | 12.49 | 429 / 430 |
stomach | 100% | 2148.64 | 359 / 359 | 100% | 14.98 | 285 / 286 |
bladder | 100% | 2588.05 | 21 / 21 | 100% | 13.35 | 502 / 504 |
uterus | 100% | 2862.46 | 170 / 170 | 100% | 16.07 | 457 / 459 |
prostate | 100% | 2366.36 | 245 / 245 | 99% | 13.85 | 499 / 502 |
skin | 100% | 4542.77 | 1809 / 1809 | 99% | 17.76 | 469 / 472 |
thymus | 100% | 2771.41 | 653 / 653 | 99% | 14.72 | 601 / 605 |
kidney | 100% | 2102.16 | 89 / 89 | 99% | 12.09 | 888 / 901 |
pancreas | 98% | 1385.63 | 321 / 328 | 99% | 11.66 | 176 / 178 |
adrenal gland | 100% | 3644.50 | 258 / 258 | 96% | 10.32 | 220 / 230 |
liver | 100% | 1831.77 | 226 / 226 | 91% | 6.58 | 369 / 406 |
adipose | 100% | 2881.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 3313.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2967.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.13 | 1 / 1 |
blood vessel | 100% | 2525.67 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2391.81 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.05 | 28 / 29 |
peripheral blood | 95% | 3203.76 | 884 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 7.59 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030011 | Biological process | maintenance of cell polarity |
GO_0030516 | Biological process | regulation of axon extension |
GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
GO_2000077 | Biological process | negative regulation of type B pancreatic cell development |
GO_0048814 | Biological process | regulation of dendrite morphogenesis |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_0046827 | Biological process | positive regulation of protein export from nucleus |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045724 | Biological process | positive regulation of cilium assembly |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_1902042 | Biological process | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0006468 | Biological process | protein phosphorylation |
GO_1903566 | Biological process | positive regulation of protein localization to cilium |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0032886 | Biological process | regulation of microtubule-based process |
GO_1900271 | Biological process | regulation of long-term synaptic potentiation |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0032515 | Biological process | negative regulation of phosphoprotein phosphatase activity |
GO_0031175 | Biological process | neuron projection development |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_1900034 | Biological process | regulation of cellular response to heat |
GO_2000466 | Biological process | negative regulation of glycogen (starch) synthase activity |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_1904781 | Biological process | positive regulation of protein localization to centrosome |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0010975 | Biological process | regulation of neuron projection development |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0070507 | Biological process | regulation of microtubule cytoskeleton organization |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0106027 | Biological process | neuron projection organization |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0021766 | Biological process | hippocampus development |
GO_0036016 | Biological process | cellular response to interleukin-3 |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_1904339 | Biological process | negative regulation of dopaminergic neuron differentiation |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0007005 | Biological process | mitochondrion organization |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0019082 | Biological process | viral protein processing |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_1901030 | Biological process | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0001954 | Biological process | positive regulation of cell-matrix adhesion |
GO_0006983 | Biological process | ER overload response |
GO_0071109 | Biological process | superior temporal gyrus development |
GO_0150101 | Biological process | regulation of microtubule anchoring at centrosome |
GO_0007623 | Biological process | circadian rhythm |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_1904886 | Biological process | beta-catenin destruction complex disassembly |
GO_2000740 | Biological process | negative regulation of mesenchymal stem cell differentiation |
GO_0045719 | Biological process | negative regulation of glycogen biosynthetic process |
GO_0046825 | Biological process | regulation of protein export from nucleus |
GO_0007212 | Biological process | G protein-coupled dopamine receptor signaling pathway |
GO_1901984 | Biological process | negative regulation of protein acetylation |
GO_0050770 | Biological process | regulation of axonogenesis |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098793 | Cellular component | presynapse |
GO_0098794 | Cellular component | postsynapse |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030877 | Cellular component | beta-catenin destruction complex |
GO_0030425 | Cellular component | dendrite |
GO_1990909 | Cellular component | Wnt signalosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0005829 | Cellular component | cytosol |
GO_0034452 | Molecular function | dynactin binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0034236 | Molecular function | protein kinase A catalytic subunit binding |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0002020 | Molecular function | protease binding |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0002039 | Molecular function | p53 binding |
GO_0005515 | Molecular function | protein binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0016301 | Molecular function | kinase activity |
GO_0051059 | Molecular function | NF-kappaB binding |
Gene name | GSK3B |
Protein name | Glycogen synthase kinase 3 beta Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) Glycogen synthase kinase-3 beta Glycogen synthase kinase-3 beta (EC 2.7.11.26) |
Synonyms | hCG_1818062 |
Description | FUNCTION: Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1 . Requires primed phosphorylation of the majority of its substrates . In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis . May also mediate the development of insulin resistance by regulating activation of transcription factors . Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase . In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes . Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA . Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin . Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules . MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease . Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex . Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair (By similarity). Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA) (By similarity). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin . Is necessary for the establishment of neuronal polarity and axon outgrowth . Phosphorylates MARK2, leading to inhibition of its activity (By similarity). Phosphorylates SIK1 at 'Thr-182', leading to sustainment of its activity . Phosphorylates ZC3HAV1 which enhances its antiviral activity . Phosphorylates SNAI1, leading to its BTRC-triggered ubiquitination and proteasomal degradation . Phosphorylates SFPQ at 'Thr-687' upon T-cell activation . Phosphorylates NR1D1 st 'Ser-55' and 'Ser-59' and stabilizes it by protecting it from proteasomal degradation. Regulates the circadian clock via phosphorylation of the major clock components including BMAL1, CLOCK and PER2 . Phosphorylates FBXL2 at 'Thr-404' and primes it for ubiquitination by the SCF(FBXO3) complex and proteasomal degradation (By similarity). Phosphorylates CLOCK AT 'Ser-427' and targets it for proteasomal degradation . Phosphorylates BMAL1 at 'Ser-17' and 'Ser-21' and primes it for ubiquitination and proteasomal degradation . Phosphorylates OGT at 'Ser-3' or 'Ser-4' which positively regulates its activity. Phosphorylates MYCN in neuroblastoma cells which may promote its degradation . Regulates the circadian rhythmicity of hippocampal long-term potentiation and BMAL1 and PER2 expression (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions, activating KAT5/TIP60 acetyltransferase activity and promoting acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer . Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors. Promotes the formation of an anti-apoptotic complex, made of DDX3X, BRIC2 and GSK3B, at death receptors, including TNFRSF10B. The anti-apoptotic function is most effective with weak apoptotic signals and can be overcome by stronger stimulation . Phosphorylates E2F1, promoting the interaction between E2F1 and USP11, stabilizing E2F1 and promoting its activity . Phosphorylates mTORC2 complex component RICTOR at 'Thr-1695' which facilitates FBXW7-mediated ubiquitination and subsequent degradation of RICTOR . Phosphorylates FXR1, promoting FXR1 ubiquitination by the SCF(FBXO4) complex and FXR1 degradation by the proteasome (By similarity). Phosphorylates interleukin-22 receptor subunit IL22RA1, preventing its proteasomal degradation (By similarity). . |
Accessions | A0A7I2V432 ENST00000677716.1 A0A7I2V2U4 A0A7I2V3G9 ENST00000678509.1 A0A7I2V3S5 ENST00000676910.1 A0A7I2V5B5 ENST00000678787.1 A0A7I2V4F3 A0A7I2V606 A0A7I2V4X3 A0A7I2V5K9 A0A7I2V2Y0 ENST00000677400.1 A0A7I2V3K8 A0A7I2V589 A0A7I2V3J4 ENST00000678350.1 ENST00000677903.1 ENST00000679068.1 A0A7I2V3N7 ENST00000264235.13 [P49841-1] ENST00000676887.1 ENST00000676775.1 ENST00000677995.1 ENST00000677362.1 ENST00000677885.1 ENST00000679201.1 ENST00000677128.1 ENST00000677875.1 ENST00000679066.1 ENST00000678377.1 ENST00000677169.1 A0A7I2V4G2 A0A7I2YQG6 A0A7I2V2V4 A0A7I2YQ81 A0A7I2V675 ENST00000677046.1 ENST00000676733.1 ENST00000677483.1 Q86TM2 B5BUC0 ENST00000676844.1 A0A7I2V5G5 Q6FI27 A0A7I2V5M2 ENST00000678159.1 ENST00000678013.1 ENST00000678064.1 ENST00000679188.1 A0A7I2YQU1 A0A7I2V441 ENST00000677648.1 A0A7I2V2T2 ENST00000678181.1 A0A3B3ITW1 ENST00000316626.6 [P49841-2] A0A7I2V4W7 A0A7I2V3Z5 A0A7I2YQB0 ENST00000678439.1 ENST00000678678.1 A0A7I2V3A4 A0A7I2YQK0 ENST00000676948.1 ENST00000678286.1 A0A7I2V2K7 ENST00000677069.1 ENST00000678608.1 ENST00000650344.2 A0A7I2V4X2 A0A7I2V3D8 ENST00000679206.1 ENST00000677423.1 A0A7I2YQK2 P49841 A0A7I2V2I5 A0A7I2V2N4 A0A7I2V626 ENST00000677034.1 A0A7I2V5P4 A0A7I2V3T3 ENST00000677338.1 ENST00000677878.1 ENST00000678561.1 ENST00000679194.1 |